Zobrazeno 1 - 6
of 6
pro vyhledávání: '"G F, Rivolta"'
Publikováno v:
PharmacoEconomics Italian Research Articles. 8:33-44
Objectives To evaluate resource utilization and related costs in the management of hemophilic patients with Factor VIII inhibitors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e2c2d54a08e511f0c0fbbfe56ef2196
https://doi.org/10.1007/bf03320556
https://doi.org/10.1007/bf03320556
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 18(2)
Although up to 50% of all haemophilic patients followed at haemophilia treatment centres (HTCs) are affected by a mild factor VIII (FVIII) or factor IX (FIX) defect, published data regarding the natural history of these disorders are scarce. To fill
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c83fc79a57d8c06be78294db60b44e6b
https://pubmed.ncbi.nlm.nih.gov/21771207
https://pubmed.ncbi.nlm.nih.gov/21771207
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 17(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::af2a32c6f9503d811ce7cd8082695673
https://pubmed.ncbi.nlm.nih.gov/20642788
https://pubmed.ncbi.nlm.nih.gov/20642788
Autor:
F, Riccardi, A, Tagliaferri, D, Martorana, G F, Rivolta, L, Valdrè, G, Rodorigo, C, Biasoli, M, D'Incà, M L, Serino, S, Macchi, D, Vincenzi, M, Arbasi, P, Pedrazzi, M, Volta, C, DI Perna, L, Ippolito, M, Savi, T M, Neri
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 16(5)
Haemophilia A (HA) is an X-linked recessive bleeding disorder caused by a lack or decrease of coagulation factor VIII activity. The molecular diagnosis of HA is challenging and a variety of different mutations have been identified throughout the F8 g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3bfb2ff786e84e589f41b647b6c61503
https://pubmed.ncbi.nlm.nih.gov/20331761
https://pubmed.ncbi.nlm.nih.gov/20331761
Autor:
G. Auerswald, Carmen Altisent, F. A. Scaraggi, V. Rossi, Jan Blatny, G. F. Rivolta, Massimo Morfini, Rainer Kobelt, A. Borel-Derlon, J. Rodriguez-Martorell
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 13(5)
Many patients with haemophilia develop inhibitors to factor VIII and require bypassing agents to provide haemostatic cover for limb- or life-threatening bleeding episodes. Due to the reduced risk of blood-borne pathogen transmission with recombinant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aabba9c885aae251619bbff37c077fdd
https://pubmed.ncbi.nlm.nih.gov/17880436
https://pubmed.ncbi.nlm.nih.gov/17880436
Publikováno v:
Cytotechnology. 19(3)
We investigated the expression of P-glycoprotein (P-gp) in 50 adults with de novo acute myeloid leukemia (AML) at the initial diagnosis in order to further define the relationship between the presence of P-gp on leukemic cells and the efficacy of two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4e6448d9c16efde4a29769fbbd2a505
https://pubmed.ncbi.nlm.nih.gov/8862011
https://pubmed.ncbi.nlm.nih.gov/8862011